NCT01814709View on ClinicalTrials.gov

A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Healthy Volunteer

Interventions

DRUG

GDC-0032

Oral doses of GDC-0032

DRUG

Itraconazole

Oral doses of Itraconazole

DRUG

Rifampin

Oral doses of Rifampin

Trial Locations (1)

75247

Dallas

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY